BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17997381)

  • 1. Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract.
    Uno S; Dragin N; Miller ML; Dalton TP; Gonzalez FJ; Nebert DW
    Free Radic Biol Med; 2008 Feb; 44(4):570-83. PubMed ID: 17997381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral benzo[a]pyrene: understanding pharmacokinetics, detoxication, and consequences--Cyp1 knockout mouse lines as a paradigm.
    Nebert DW; Shi Z; Gálvez-Peralta M; Uno S; Dragin N
    Mol Pharmacol; 2013 Sep; 84(3):304-13. PubMed ID: 23761301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes.
    Iqbal J; Sun L; Cao J; Yuen T; Lu P; Bab I; Leu NA; Srinivasan S; Wagage S; Hunter CA; Nebert DW; Zaidi M; Avadhani NG
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11115-20. PubMed ID: 23776235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
    Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
    Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
    Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteria.
    Walker NJ; Crofts FG; Li Y; Lax SF; Hayes CL; Strickland PT; Lucier GW; Sutter TR
    Carcinogenesis; 1998 Mar; 19(3):395-402. PubMed ID: 9525272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
    Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
    Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequential.
    Dragin N; Dalton TP; Miller ML; Shertzer HG; Nebert DW
    J Biol Chem; 2006 Jul; 281(27):18591-600. PubMed ID: 16636061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells.
    Nakajima M; Iwanari M; Yokoi T
    Toxicol Lett; 2003 Sep; 144(2):247-56. PubMed ID: 12927368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype.
    Shi Z; Dragin N; Miller ML; Stringer KF; Johansson E; Chen J; Uno S; Gonzalez FJ; Rubio CA; Nebert DW
    Int J Cancer; 2010 Nov; 127(10):2334-50. PubMed ID: 20127859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate.
    Uno S; Dalton TP; Dragin N; Curran CP; Derkenne S; Miller ML; Shertzer HG; Gonzalez FJ; Nebert DW
    Mol Pharmacol; 2006 Apr; 69(4):1103-14. PubMed ID: 16377763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cytochrome P450 1 (Cyp1) by vanadium in hepatic tissue and isolated hepatocyte of C57BL/6 mice.
    Abdelhamid G; Amara IE; Anwar-Mohamed A; El-Kadi AO
    Arch Toxicol; 2013 Aug; 87(8):1531-43. PubMed ID: 23423713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential induction of CYP1A1 and CYP1B1 in CCSP-positive cells.
    Chang H; Chang LW; Cheng YH; Tsai WT; Tsai MX; Lin P
    Toxicol Sci; 2006 Jan; 89(1):205-13. PubMed ID: 16237193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype of the Cyp1a1/1a2/1b1-/- triple-knockout mouse.
    Dragin N; Shi Z; Madan R; Karp CL; Sartor MA; Chen C; Gonzalez FJ; Nebert DW
    Mol Pharmacol; 2008 Jun; 73(6):1844-56. PubMed ID: 18372398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
    Chang TK; Chen J; Yang G; Yeung EY
    J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice.
    Derkenne S; Curran CP; Shertzer HG; Dalton TP; Dragin N; Nebert DW
    Pharmacogenet Genomics; 2005 Jul; 15(7):503-11. PubMed ID: 15970798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential time-course and dose-response relationships of TCDD-induced CYP1B1, CYP1A1, and CYP1A2 proteins in rats.
    Santostefano MJ; Ross DG; Savas U; Jefcoate CR; Birnbaum LS
    Biochem Biophys Res Commun; 1997 Apr; 233(1):20-4. PubMed ID: 9144388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities.
    Vogel C; Donat S; Döhr O; Kremer J; Esser C; Roller M; Abel J
    Arch Toxicol; 1997; 71(6):372-82. PubMed ID: 9195019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of phase I and phase II genes in mouse embryonic stem cells cultured in the presence of 2,3,7,8-tetrachlorodibenzo-para-dioxin.
    Neri T; Merico V; Garagna S; Redi CA; Zuccotti M
    Biochim Biophys Acta; 2008 May; 1780(5):826-36. PubMed ID: 18334230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.